Principal Investigator
Bradley Gampel
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20241043
Clinical Trial Summary
A Phase II Trial Evaluating Chemotherapy followed by Response-Based Reduced Radiation Therapy for Patients with Central Nervous System Germinomas
Phase
Phase II
Funding Agency/Sponsor
National Cooperative Group
Disease
Pediatric Cancer
Contact Information
Phone Number
305-243-2647